ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how the rules link it today.

2 links0 made here, not in the record2 judgments1 judge (the rules as one: Rule based)7 record changes seen
Rule basedRecord updated on ClinicalTrials.gov
Sep 28Oct 5Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07042295Treatment With Amivantamaband Hyaluronidase orCetuximab for Advanced SkinCancer in People With aWeakened Immune SystemNational Cancer Institute (NCIPhase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Sep 30 · ClinicalTrials.gov record · Version of 2026-09-30Oct 13 · ClinicalTrials.gov record · Version of 2026-10-13Oct 15 · ClinicalTrials.gov record · Version of 2026-10-15Nov 2 · ClinicalTrials.gov record · Version of 2026-11-02Nov 4 · ClinicalTrials.gov record · Version of 2026-11-04Nov 5 · ClinicalTrials.gov record · Version of 2026-11-05Nov 18 · ClinicalTrials.gov record · Version of 2026-11-18Version of 2026-11-18DRUGSINT011590Entry “Amivantamab and Recombinant Hu…›As of now · Rule based · TestedTestedCetuximabIntervention entry›As of now · Rule based · ComparatorComparator

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

INT011590

From the registry record1 judgment on this link
Role in the study, from the registry to what was judged
RegistryEntry “Amivantamab and Recombinant Human Hyaluronidase”the record gives no role
→judged

All judgments on this study

WhenLinkJudgeDecisionState
Sep 30The record itselfClinicalTrials.gov recordVersion of 2026-09-30Record change
Oct 13The record itselfClinicalTrials.gov recordVersion of 2026-10-13Record change
Oct 15The record itselfClinicalTrials.gov recordVersion of 2026-10-15Record change
Nov 2The record itselfClinicalTrials.gov recordVersion of 2026-11-02Record change
Nov 4The record itselfClinicalTrials.gov recordVersion of 2026-11-04Record change
Nov 5The record itselfClinicalTrials.gov recordVersion of 2026-11-05Record change
Nov 18The record itselfClinicalTrials.gov recordVersion of 2026-11-18Record change
As of nowINT011590Rule based · role ruleTestedCurrent
As of nowCetuximabRule based · role ruleComparatorCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.